中文 | English
Return
Total: 10 , 1/1
Show Home Prev Next End page: GO
MeSH:(Prostatic Neoplasms, Castration-Resistant/drug therapy/pathology)

1.Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial.

Byung Ha CHUNG ; Jian HUANG ; Hiroji UEMURA ; Young Deuk CHOI ; Zhang-Qun YE ; Hiroyoshi SUZUKI ; Taek Won KANG ; Da-Lin HE ; Jae Young JOUNG ; Sabine D BROOKMAN-MAY ; Sharon MCCARTHY ; Amitabha BHAUMIK ; Anildeep SINGH ; Suneel MUNDLE ; Simon CHOWDHURY ; Neeraj AGARWAL ; Ding-Wei YE ; Kim N CHI ; Hirotsugu UEMURA

Asian Journal of Andrology 2023;25(6):653-661

2.Recent advances in treatment of patients with castration-resistant prostate cancer after docetaxel failure.

Bi-de CHEN ; Shi-cheng YU ; Gong-hui LI

Journal of Zhejiang University. Medical sciences 2014;43(1):115-118

3.A case of metastatic castration-resistant prostate cancer by abiraterone treatment.

Liuxun LI ; Zhi LONG ; Leye HE

Journal of Central South University(Medical Sciences) 2015;40(6):688-692

4.Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity.

Jian HUANG ; Wang LIU ; Bi-Yun LIN ; Jean C LI ; Jane LU ; Ben-Yi LI

Asian Journal of Andrology 2023;25(2):198-207

5.The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment.

Ja Yoon KU ; Jeong Zoo LEE ; Hong Koo HA

Korean Journal of Urology 2015;56(10):689-694

6.Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer.

Jaeyoon JUNG ; Chunwoo LEE ; Chanwoo LEE ; Taekmin KWON ; Dalsan YOU ; In Gab JEONG ; Jun Hyuk HONG ; Hanjong AHN ; Choung Soo KIM

Korean Journal of Urology 2015;56(9):630-636

7.Indirubin inhibits the proliferation of prostate cancer PC-3 cells.

Yun-fei WEI ; Jian SU ; Zhong-lei DENG ; Chen ZHU ; Lin YUAN ; Zi-jie LU ; Qing-yi ZHU

National Journal of Andrology 2015;21(9):788-791

8.Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.

Ho Seong JANG ; Kyo Chul KOO ; Kang Su CHO ; Byung Ha CHUNG

Yonsei Medical Journal 2016;57(5):1070-1078

9.Inhibitory effect of polyphyllin Ⅰ on the proliferation of prostate cancer PC3 cells via ERK1/2/P65/DNMT1 and its molecular mechanism.

Pei-Liang ZOU ; Qiu-Hong ZHANG ; Jian-Fu ZHOU ; Rong-Wu LIN ; Zhi-Qiang CHEN ; Song-Tao XIANG

National Journal of Andrology 2018;24(3):199-205

10.Exponential Rise in Prostate-Specific Antigen (PSA) during Anti-Androgen Withdrawal Predicts PSA Flare after Docetaxel Chemotherapy in Patients with Castration-Resistant Prostate Cancer.

Kyung Seok HAN ; Sung Joon HONG

Yonsei Medical Journal 2015;56(2):368-374

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 10 , 1/1 Show Home Prev Next End page: GO